annual total liabilities:
$2.42B-$188.06M(-7.22%)Summary
- As of today (May 29, 2025), IONS annual total liabilities is $2.42 billion, with the most recent change of -$188.06 million (-7.22%) on December 31, 2024.
- During the last 3 years, IONS annual total liabilities has risen by +$575.37 million (+31.27%).
- IONS annual total liabilities is now -7.22% below its all-time high of $2.60 billion, reached on December 31, 2023.
Performance
IONS Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$2.34B-$78.10M(-3.23%)Summary
- As of today (May 29, 2025), IONS quarterly total liabilities is $2.34 billion, with the most recent change of -$78.10 million (-3.23%) on March 31, 2025.
- Over the past year, IONS quarterly total liabilities has dropped by -$130.19 million (-5.28%).
- IONS quarterly total liabilities is now -10.74% below its all-time high of $2.62 billion, reached on September 30, 2023.
Performance
IONS quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
IONS Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.2% | -5.3% |
| 3 y3 years | +31.3% | +29.2% |
| 5 y5 years | +56.0% | +53.7% |
IONS Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -7.2% | +31.3% | -10.7% | +29.2% |
| 5 y | 5-year | -7.2% | +56.0% | -10.7% | +57.5% |
| alltime | all time | -7.2% | >+9999.0% | -10.7% | >+9999.0% |
IONS Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $2.34B(-3.2%) |
| Dec 2024 | $2.42B(-7.2%) | $2.42B(-0.1%) |
| Sep 2024 | - | $2.42B(-0.4%) |
| Jun 2024 | - | $2.43B(-1.6%) |
| Mar 2024 | - | $2.47B(-5.2%) |
| Dec 2023 | $2.60B(+32.8%) | $2.60B(-0.6%) |
| Sep 2023 | - | $2.62B(+3.0%) |
| Jun 2023 | - | $2.54B(+6.0%) |
| Mar 2023 | - | $2.40B(+22.3%) |
| Dec 2022 | $1.96B(+6.6%) | $1.96B(+7.3%) |
| Sep 2022 | - | $1.83B(-0.2%) |
| Jun 2022 | - | $1.83B(+1.2%) |
| Mar 2022 | - | $1.81B(-1.7%) |
| Dec 2021 | $1.84B(+11.8%) | $1.84B(-2.4%) |
| Sep 2021 | - | $1.88B(-1.6%) |
| Jun 2021 | - | $1.91B(+22.1%) |
| Mar 2021 | - | $1.57B(-4.8%) |
| Dec 2020 | $1.65B(+6.3%) | $1.65B(+10.6%) |
| Sep 2020 | - | $1.49B(+0.3%) |
| Jun 2020 | - | $1.48B(-2.4%) |
| Mar 2020 | - | $1.52B(-1.8%) |
| Dec 2019 | $1.55B(+4.6%) | $1.55B(+10.8%) |
| Sep 2019 | - | $1.40B(-1.7%) |
| Jun 2019 | - | $1.42B(-1.9%) |
| Mar 2019 | - | $1.45B(-2.2%) |
| Dec 2018 | $1.48B(+54.6%) | $1.48B(+5.2%) |
| Sep 2018 | - | $1.41B(-1.5%) |
| Jun 2018 | - | $1.43B(+56.7%) |
| Mar 2018 | - | $912.46M(-4.7%) |
| Dec 2017 | $957.49M(+17.8%) | $957.49M(+12.0%) |
| Sep 2017 | - | $854.89M(-2.3%) |
| Jun 2017 | - | $875.26M(-0.8%) |
| Mar 2017 | - | $882.19M(+8.5%) |
| Dec 2016 | $812.90M(+8.8%) | $812.90M(+15.5%) |
| Sep 2016 | - | $703.95M(+0.6%) |
| Jun 2016 | - | $699.90M(-2.5%) |
| Mar 2016 | - | $717.66M(-3.9%) |
| Dec 2015 | $747.11M(+7.0%) | $747.11M(+0.6%) |
| Sep 2015 | - | $742.59M(+9.9%) |
| Jun 2015 | - | $675.94M(-0.5%) |
| Mar 2015 | - | $679.58M(-2.6%) |
| Dec 2014 | $698.03M(+48.9%) | $698.03M(+55.5%) |
| Sep 2014 | - | $449.03M(-0.4%) |
| Jun 2014 | - | $450.92M(-2.1%) |
| Mar 2014 | - | $460.51M(-1.8%) |
| Dec 2013 | $468.77M(+29.2%) | $468.77M(-2.4%) |
| Sep 2013 | - | $480.47M(+24.0%) |
| Jun 2013 | - | $387.57M(+10.1%) |
| Mar 2013 | - | $351.87M(-3.0%) |
| Dec 2012 | $362.92M(+15.8%) | $362.92M(+15.1%) |
| Sep 2012 | - | $315.40M(-0.8%) |
| Jun 2012 | - | $318.08M(-0.6%) |
| Mar 2012 | - | $319.94M(+2.1%) |
| Dec 2011 | $313.46M(+2.5%) | $313.46M(-1.7%) |
| Sep 2011 | - | $318.96M(+0.5%) |
| Jun 2011 | - | $317.36M(+14.1%) |
| Mar 2011 | - | $278.24M(-9.1%) |
| Dec 2010 | $305.94M(-13.9%) | $305.94M(-5.0%) |
| Sep 2010 | - | $322.15M(-6.4%) |
| Jun 2010 | - | $344.12M(+9.1%) |
| Mar 2010 | - | $315.29M(-11.2%) |
| Dec 2009 | $355.12M(-24.4%) | $355.12M(-5.5%) |
| Sep 2009 | - | $375.75M(-6.8%) |
| Jun 2009 | - | $403.34M(-4.4%) |
| Mar 2009 | - | $421.84M(-10.2%) |
| Dec 2008 | $469.90M(+89.0%) | $469.90M(-1.5%) |
| Sep 2008 | - | $476.94M(-6.3%) |
| Jun 2008 | - | $509.23M(+55.3%) |
| Mar 2008 | - | $327.95M(+31.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2007 | $248.62M(+57.3%) | $248.62M(+22.6%) |
| Sep 2007 | - | $202.82M(+0.9%) |
| Jun 2007 | - | $201.04M(-25.7%) |
| Mar 2007 | - | $270.47M(+71.2%) |
| Dec 2006 | $158.00M(-3.5%) | $158.00M(+2.5%) |
| Sep 2006 | - | $154.17M(-1.5%) |
| Jun 2006 | - | $156.45M(-1.5%) |
| Mar 2006 | - | $158.79M(-3.0%) |
| Dec 2005 | $163.71M(-41.6%) | $163.71M(-5.6%) |
| Sep 2005 | - | $173.34M(-36.0%) |
| Jun 2005 | - | $270.71M(-3.2%) |
| Mar 2005 | - | $279.80M(-0.3%) |
| Dec 2004 | $280.56M(+4.8%) | $280.56M(+2.8%) |
| Sep 2004 | - | $272.91M(+1.7%) |
| Jun 2004 | - | $268.35M(+1.2%) |
| Mar 2004 | - | $265.17M(-1.0%) |
| Dec 2003 | $267.76M(-5.5%) | $267.76M(+3.0%) |
| Sep 2003 | - | $260.03M(+0.8%) |
| Jun 2003 | - | $258.02M(-8.1%) |
| Mar 2003 | - | $280.82M(-0.8%) |
| Dec 2002 | $283.21M(+46.0%) | $283.21M(+11.5%) |
| Sep 2002 | - | $253.96M(-1.1%) |
| Jun 2002 | - | $256.86M(+30.5%) |
| Mar 2002 | - | $196.75M(+1.4%) |
| Dec 2001 | $193.96M(+65.9%) | $193.96M(+10.0%) |
| Sep 2001 | - | $176.38M(+24.6%) |
| Jun 2001 | - | $141.60M(+19.1%) |
| Mar 2001 | - | $118.90M(+1.7%) |
| Dec 2000 | $116.89M(+14.3%) | $116.89M(+5.7%) |
| Sep 2000 | - | $110.61M(+3.1%) |
| Jun 2000 | - | $107.27M(+3.2%) |
| Mar 2000 | - | $103.96M(+1.6%) |
| Dec 1999 | $102.31M(+2.0%) | $102.31M(-1.1%) |
| Sep 1999 | - | $103.40M(+2.9%) |
| Jun 1999 | - | $100.50M(+1.9%) |
| Mar 1999 | - | $98.60M(-1.7%) |
| Dec 1998 | $100.30M(+20.8%) | $100.30M(+5.7%) |
| Sep 1998 | - | $94.90M(-9.5%) |
| Jun 1998 | - | $104.90M(+36.8%) |
| Mar 1998 | - | $76.70M(-7.6%) |
| Dec 1997 | $83.00M(+93.5%) | $83.00M(+48.5%) |
| Sep 1997 | - | $55.90M(-2.1%) |
| Jun 1997 | - | $57.10M(+22.0%) |
| Mar 1997 | - | $46.80M(+9.1%) |
| Dec 1996 | $42.90M(+81.0%) | $42.90M(+72.3%) |
| Sep 1996 | - | $24.90M(-3.5%) |
| Jun 1996 | - | $25.80M(-5.1%) |
| Mar 1996 | - | $27.20M(+14.8%) |
| Dec 1995 | $23.70M(+15.0%) | $23.70M(-11.9%) |
| Sep 1995 | - | $26.90M(+32.5%) |
| Jun 1995 | - | $20.30M(+3.0%) |
| Mar 1995 | - | $19.70M(-4.4%) |
| Dec 1994 | $20.60M(+1.5%) | $20.60M(+6.2%) |
| Sep 1994 | - | $19.40M(+16.9%) |
| Jun 1994 | - | $16.60M(-3.5%) |
| Mar 1994 | - | $17.20M(-15.3%) |
| Dec 1993 | $20.30M(+29.3%) | $20.30M(+21.6%) |
| Sep 1993 | - | $16.70M(+17.6%) |
| Jun 1993 | - | $14.20M(-0.7%) |
| Mar 1993 | - | $14.30M(-8.9%) |
| Dec 1992 | $15.70M(+8.3%) | $15.70M(+0.6%) |
| Sep 1992 | - | $15.60M(+3.3%) |
| Jun 1992 | - | $15.10M(+4.9%) |
| Mar 1992 | - | $14.40M(-0.7%) |
| Dec 1991 | $14.50M(+457.7%) | $14.50M(+55.9%) |
| Sep 1991 | - | $9.30M(-7.9%) |
| Jun 1991 | - | $10.10M(+62.9%) |
| Mar 1991 | - | $6.20M(+138.5%) |
| Dec 1990 | $2.60M | $2.60M |
FAQ
- What is Ionis Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals annual total liabilities year-on-year change?
- What is Ionis Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals quarterly total liabilities year-on-year change?
What is Ionis Pharmaceuticals annual total liabilities?
The current annual total liabilities of IONS is $2.42B
What is the all time high annual total liabilities for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high annual total liabilities is $2.60B
What is Ionis Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, IONS annual total liabilities has changed by -$188.06M (-7.22%)
What is Ionis Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of IONS is $2.34B
What is the all time high quarterly total liabilities for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high quarterly total liabilities is $2.62B
What is Ionis Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, IONS quarterly total liabilities has changed by -$130.19M (-5.28%)